Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis

Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis

Background: The detection of additional autoantibodies is of great concern in systemic sclerosis (SSc) when those included in the ACR/EULAR classification are negative. In this context, the interest of antifibrillarin (anti-U3RNP) autoantibodies (AFAs) in the routine evaluation of SSc remains unclea...

Full description

Bibliographic Details
Main Authors: Audrey Benyamine, Daniel Bertin, Noémie Resseguier, Xavier Heim, Julien Bermudez, David Launay, Sylvain Dubucquoi, Adrian Hij, Dominique Farge, Alain Lescoat, Isabelle Bahon-Riedinger, Nouria Benmostefa, Luc Mouthon, Jean-Robert Harlé, Gilles Kaplanski, Pascal Rossi, Nathalie Bardin, Brigitte Granel
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Diagnostics
Subjects:
systemic sclerosis
autoantibodies
antifibrillarin antibodies
anti-U3 RNP antibodies
Online Access:https://www.mdpi.com/2075-4418/11/6/1064

Internet

https://www.mdpi.com/2075-4418/11/6/1064

Similar Items